Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Rapid Response Innovation Awards, 2010
    Screen for Novel Glucocerebrosidase-Interacting Parkinson's Genes

    Objective/Rationale:
    Our goal is to discover new genes that lead to Parkinson’s disease.  Most of the known causes of Parkinson’s disease are rare and account for a minority of patients. However, it...

  • Rapid Response Innovation Awards, 2010
    Nasal PD Treatment-Proof-of-Concept

    Objective/Rationale:

    • In animal models of PD, brain injections of certain neurotrophic factors prevent degeneration of midbrain dopaminergic neurons.
    • Clinical testing of brain injected gene vectors...
  • Rapid Response Innovation Awards, 2010
    Functional Genomic Screening to Identify Novel Regulators of Parkin

    Objective/Rationale:    
    In normal cells, Parkin protein senses damage of critical cellular organelles known as mitochondria and promotes recycling of their contents. Mitochondria are the energy...

  • MJFF Research Grant, 2010
    Role of H1N1 Influenza Virus in the Etiology of Parkinson's Disease

    Objective/Rationale:    
    Viruses (including influenza) have also been proposed to be an etiological agent for PD based on the appearance of otherwise non-explained clusters of parkinsonism. Recently...

  • Rapid Response Innovation Awards, 2010
    Characterization of PARK16

    Objective/Rationale:
    Recently, a novel region of the genome containing genetic information predisposing to the development of Parkinson’s disease has been discovered through a collaborative study of...

  • Rapid Response Innovation Awards, 2010
    Deciphering the Molecular Effects of Alpha-Synuclein in the Nucleus: DNA Binding and Transcriptional Dysregulation

    Objective/Rationale:
    A-synuclein, the main component of Lewy bodies, is thought to be present mostly on nerve terminals. Although the function of a-synuclein is unclear, its presence in the nucleus of...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.